Australia markets closed

Aurobindo Pharma Limited (AUROPHARMA.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
1,304.25+50.50 (+4.03%)
At close: 03:29PM IST
Full screen
Previous close1,253.75
Open1,256.95
Bid1,298.00 x 0
Ask1,298.05 x 0
Day's range1,254.90 - 1,311.00
52-week range723.40 - 1,311.00
Volume47,607
Avg. volume50,766
Market cap763.756B
Beta (5Y monthly)0.55
PE ratio (TTM)24.08
EPS (TTM)54.16
Earnings date10 Aug 2024 - 14 Aug 2024
Forward dividend & yield4.50 (0.36%)
Ex-dividend date20 Feb 2024
1y target est762.03
  • Investing.com

    Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead

    Aurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year growth. Sales increased by 17%, while EBITDA surged by an impressive 68%, surpassing both Goldman Sachs (NYSE:GS)' projections and those of the broader market. The EBITDA margin also exceeded forecasts, reaching 22.3%, which is 101 basis points higher than Goldman Sachs' estimate.